A technical win is not a buying decision.
This note demonstrates the DealCause reasoning standard using public evidence only. It is not client work, not a case study, and not proof that DealCause improves win rates.
What the public evidence supports
Gartner's public research abstract says excessive technical focus can fail to engage buying teams around business outcomes, and that POCs can consume substantial resources without necessarily converting.
Winning by Design frames enterprise decisions around business impact, stakeholder roles, decision criteria and the buying process rather than a feature checklist alone.
Vivun defines a technical win around satisfying technical requirements and removing technical barriers. That definition is useful precisely because it is narrower than a signed commercial decision.
Seller-side records can show sequence, artifacts and stated objections. They cannot, by themselves, prove the buyer's private intent or the true causal reason for a loss. Direct buyer evidence is a separate evidentiary layer.
What DealCause would inspect after a technical pass
- whether business-value criteria were defined before the evaluation;
- whether the technical success criteria map to a buying decision rather than product capability alone;
- which stakeholders and approval gates are visible in the record;
- whether procurement, security, legal, pricing or timing changed after technical validation;
- whether the champion translated technical proof into an executive decision case;
- which explanations are supported, contradicted, or still UNKNOWN.
What this note does not prove
It does not prove that any one mechanism caused a particular deal to fail, that seller records reveal buyer truth, or that a three-to-five POC cohort estimates market prevalence. Those conclusions require stronger evidence. DealCause's paid work keeps those boundaries visible rather than silently filling them with plausible narrative.
Why this matters
If a team repeatedly records “technical success” but cannot explain the commercial outcome with evidence, the useful question is not simply “why did we lose?” It is: which decision mechanism is supported by the record, which competing explanation survives, and what should the next cohort test differently?
Request the 1-page evidence schema →
Omar Polizzi · Founder & Principal, DealCause · dealcausehq@gmail.com